Ethanol is a well-known inducer of CYP2E1; whether or not it is an ind
ucer of other cytochromes has not been investigated systematically, Th
e aim of our study was to evaluate the impact of ethanol consumption o
n the activity of CYP1A2, which has been shown to be influenced by dru
gs (inhibited or induced). We evaluated CYP1A2 activity by the ratio o
f the molar urinary concentrations of the three end products of paraxa
nthine demethylation of caffeine to the molar concentration of a parax
anthine 8-hydroxylation product, This urinary metabolite ratio has pre
viously been shown to correlate with caffeine clearance. The caffeine
metabolites were measured in urine collected during the 3 hours after
oral administration of 200 mg caffeine. The caffeine test was performe
d in 12 smokers (>25 cigarettes/day) and 12 nonsmokers, all of whom we
re alcoholic inpatients (daily intake > 100 gm absolute ethanol), with
in the first 3 days of their hospital stay and after 14 days of abstin
ence from ethanol. In alcoholic patients who were smokers the molar ur
inary concentration ratio was 3.14 +/- 0.97 before withdrawal and 4.01
+/- 0.92 after 14 days of abstinence from ethanol. In contrast, in al
coholic patients who were nonsmokers it was 2.62 +/- 0.95 and 2.18 +/-
0.96 before and after withdrawal, respectively, In volunteers who wer
e smokers the molar urinary concentration ratio was 5.02 +/- 1.51, whe
reas in volunteers who were nonsmokers it was 3.22 +/- 1.46. Our resul
ts confirm the well-known induction of CYP1A2 activity by tobacco smok
ing and show that this induction is masked by long-term ethanol consum
ption.